Skip to main content

Tetramethylpyrazine induces heme oxygenase-1 expression and attenuates myocardial ischemia/reperfusion injury in rats

Abstract

The accumulation of oxygen free radicals and activation of neutrophils are strongly implicated as pathophysiological mechanisms mediating myocardial ischemia/reperfusion injury. Heme oxygenase-1 (HO-1) has been reported to play a protective role in oxidative tissue injuries. In this study, the cardioprotective activity of tetramethylpyrazine (TMP), an active ingredient of Chinese medicinal herb Ligusticum wallichii Franchat, was evaluated in an open-chest anesthetized rat model of myocardial ischemia/reperfusion injury. Pretreatment with TMP (5 and 10 mg/kg, i.v.) before left coronary artery occlusion significantly suppressed the occurrence of ventricular fibrillation. After 45 min of ischemia and 1 h of reperfusion, TMP (5 and 10 mg/kg) caused a significant reduction in infarct size and induced HO-1 expression in ischemic myocardium. The HO inhibitor ZnPP (50 µg/rat) markedly reversed the anti-infarct action of TMP. Superoxide anion production in ischemic myocardium after 10 min reperfusion was inhibited by TMP. Furthermore, TMP (200 and 500 µM) significantly suppressed fMLP (800 nM)-activated human neutrophil migration and respiratory burst. In conclusion, TMP suppresses ischemia-induced ventricular arrhythmias and reduces the infarct size resulting from ischemia/reperfusion injury in vivo. This cardioprotective activity of TMP may be associated with its antioxidant activity via induction of HO-1 and with its capacity for neutrophil inhibition.

References

  1. Maxwell S.R.J., Lip G.Y.H. (1997) Reperfusion injury: a review of the pathophysiology, clinical manifestations and therapeutic options. Int. J. Cardiol. 58: 95–117

    PubMed  CAS  Article  Google Scholar 

  2. Park J.L., Lucchesi B.R. (1998) Mechanisms of myocardial reperfusion injury. Ann. Thorac. Surg. 68: 1905–1912

    Article  Google Scholar 

  3. Buja L.M. (2005) Myocardial ischemia and reperfusion injury. Cardiovasc. Pathol. 14: 170–175

    PubMed  CAS  Article  Google Scholar 

  4. Moens A.L., Claeys M.J., Timmermans J.P., Vrints C.J. (2005) Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process. Int. J. Cardiol. 100: 179–190

    PubMed  CAS  Article  Google Scholar 

  5. Takahashi T., Morita K., Akagi R., Sassa S. (2004) Heme Oxygenase-1: a novel therapeutic target in oxidative tissue injuries. Curr. Med. Chem. 11: 1545–1561

    PubMed  CAS  Google Scholar 

  6. Yet S.F., Tian R., Layne M.D., Wang Z.Y., Maemura K., Solovyeva M., Ith B., Melo L.G., Zhang L., Ingwall J.S., Dzau V.J., Lee M.E., Perrella M.A. (2001) Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice. Circ. Res. 89: 168–173

    PubMed  CAS  Google Scholar 

  7. Yet S.F., Perrella M.A., Layne M.D., Hsieh C.M., Maemura K., Kobzik L., Wiesel P., Christou H., Kourembanas S., Lee M.E. (1999) Hypoxia induces severe right ventricular dilatation and infarction in heme oxygenase-1 null mice. J. Clin. Invest. 103: R23-R29

    PubMed  CAS  Google Scholar 

  8. Vulapalli S.R., Chen Z., Chua B.H., Wang T., Liang C.S. (2002) Cardioselective overexpression of HO-1 prevents I/R-induced cardiac dysfunction and apoptosis. Am. J. Physiol. 283: H688-H694

    CAS  Google Scholar 

  9. Masini E., Vannacci A., Marzocca C., Pierpaoli S., Giannini L., Fantappie O., Mazzanti R., Mannaioni P.F. (2003) Heme oxygenase-1 and the ischemia-reperfusion injury in the rat heart. Exp. Biol. Med. 228: 546–549

    CAS  Google Scholar 

  10. Guo S.K., Chen K.J., Qian Z.H., Weng W.L., Qian M.Y. (1983) Tetramethylpyrazine in the treatment of cardiovascular and cerebrovascular diseases. Planta Medica 47: 89

    PubMed  CAS  Google Scholar 

  11. Zhang Z., Wei T., Hou J., Li G., Yu S., Xin W. (2003) Tetramethylpyrazine scavenges superoxide anion and decreases nitric oxide production in human polymorphonuclear leukocytes. Life Sci. 72: 2465–2472

    PubMed  CAS  Article  Google Scholar 

  12. Zhang Z., Wei T., Hou J., Li G., Yu S., Xin W. (2003) Iron-induced oxidative damage and apoptosis in cerebellar granule cells: attenuation by tetramethylpyrazine and ferulic acid. Eur. J. Pharmacol. 467: 41–47

    PubMed  CAS  Article  Google Scholar 

  13. Lee L.M., Liu C.F., Yang P.P. (2002) Effect of tetramethylpyrazine on lipid peroxidation in streptozotocin-induced diabetic mice. Am. J. Chin. Med. 30: 601–608

    PubMed  CAS  Article  Google Scholar 

  14. Chen J.L., Zhou T., Chen W.X., Zhu J.S., Chen N.W., Zhang M.J., Wu Y.L. (2003) Effect of tetramethylpyrazine on P-selectin and hepatic/renal ischemia and reperfusion injury in rats. World J. Gastroenterol. 9: 1563–1566

    PubMed  CAS  Google Scholar 

  15. Feng L., Xiong Y., Cheng F., Zhang L., Li S., Li Y. (2004) Effect of ligustrazine on ischemia-reperfusion injury in murine kidney. Transplant. Proc. 36: 1949–1951

    PubMed  CAS  Article  Google Scholar 

  16. Fujimoto H., Ohno M., Ayabe S., Kobayashi H., Ishizaka N., Kimura H., Yoshida K., Nagai R. (2004) Carbon monoxide protects against cardiac ischemia–reperfusion injury in vivo via MAPK and Akt–eNOS pathways.Arterioscler. Thromb. Vasc. Biol. 24: 1848–1853

    PubMed  CAS  Article  Google Scholar 

  17. Gyllenhammer H. (1987) Lucigenin chemiluminescence in the assessment of neutrophil superoxide production. J. Immunol. Methods 97: 209–213

    Article  Google Scholar 

  18. Lee Y.M., Hsiao G., Chen H.R., Chen Y.C., Sheu J.R., Yen M.H. (2001) Magnolol reduces myocardial ischemiarreperfusion injury via neutrophil inhibition in rats. Eur. J. Pharmacol. 422: 159–167

    PubMed  CAS  Article  Google Scholar 

  19. Hsiao G., Teng C.M., Sheu J.R., Cheng Y.W., Lam K.K., Lee Y.M., Wu T.S., Yen M.H. (2001) Cinnamophillin as a novel antiperoxidative cytoprotectant and free radical scavenger. Biochim. Biophys. Acta 1525: 77–88

    PubMed  CAS  Google Scholar 

  20. Kukreja R.C., Hess M.L. (1992) The oxygen free radical system: from equations through membrane-protein interactions to cardiovascular injury and protection. Cardiovasc. Res. 26: 641–655

    PubMed  CAS  Google Scholar 

  21. Maines M.D. (1997) The heme oxygenase system: a regulator of second messenger gases. Annu. Rev. Pharmacol. Toxicol. 37: 517–554

    PubMed  CAS  Article  Google Scholar 

  22. Stocker R., Yamamoto Y., McDonagh A.F., Glazer A.N., Ames B.N. (1987) Bilirubin is an antioxidant of possible physiological importance. Science 235: 1043–1046

    PubMed  CAS  Google Scholar 

  23. Wagener F.A., Volk H.D., Willis D., Abraham N.G., Soares M.P., Adema G.J., Figdor C.G. (2003) Different faces of the heme-heme oxygenase system in inflammation. Pharmacol. Rev. 55: 551–571

    PubMed  CAS  Article  Google Scholar 

  24. Jordan J.E., Zhao Z.Q., Vinten-Johansen J. (1999) The role of neutrophils in myocardial ischemia–reperfusion injury. Cardiovasc. Res. 43: 860–878

    PubMed  CAS  Article  Google Scholar 

  25. Dai X.Z., Bache R.J. (1985) Coronary and systemic haemodynamic effect of tetramethylpyrazine in the dog. J. Cardiovasc. Pharmacol. 7: 841–849

    PubMed  CAS  Article  Google Scholar 

  26. Lin C.I., Wu S.L., Tao P.L., Chen H.M., Wei J. (1993) The role of cyclic AMP and phosphodiesterase activity in the mechanism of action of tetramethylpyrazine on human and dog cardiac and dog coronary arterial tissues. J. Pharm. Pharmacol. 45: 963–966

    PubMed  CAS  Google Scholar 

  27. Shan Au A.L., Kwan Y.W., Kwok C.C., Zhang R.Z., He G.W. (2003) Mechanisms responsible for the in vitro relaxation of ligustrazine on porcine left anterior descending coronary artery. Eur. J. Pharmacol. 468: 199–207

    PubMed  CAS  Article  Google Scholar 

  28. Liu S.Y., Sylvester D.M. (1990) Antithrombotic/antiplatelet activity of tetramethylpyrazine. Thromb. Res. 58: 129–140

    PubMed  CAS  Article  Google Scholar 

  29. Liu S.Y., Sylvester D.M. (1994) Antiplatelet activity of tetramethylpyrazine. Thromb. Res. 75: 51–62

    PubMed  CAS  Article  Google Scholar 

  30. Zou L.Y., Hao X.M., Zhang G.Q., Zhang M., Guo J.H., Liu T.F. (2001) Effect of tetramethyl pyrazine on L-type calcium channel in rat ventricular myocytes. Can. J. Physiol. Pharmacol. 79: 621–626

    PubMed  CAS  Article  Google Scholar 

  31. Wong K.L., Chan P., Huang W.C., Yang T.L., Liu I.M., Lai T.Y., Tsai C.C., Cheng J.T. (2003) Effect of tetramethylpyrazine on potassium channels to lower calcium concentration in cultured aortic smooth muscle cells. Clin. Exp. Pharmacol. Physiol. 30: 793–798

    PubMed  CAS  Article  Google Scholar 

  32. Feng J., Liu R., Wu G., Tang S. (1997) Effects of tetramethylpyrazine on the release of PGI2 and TXA2 in the hypoxic isolated rat heart. Mol. Cell. Biochem. 167: 153–158

    PubMed  CAS  Article  Google Scholar 

  33. Parratt J. (1993) Endogenous myocardial protective (antiarrhythmic) substances. Cardiovasc. Res. 27: 693–702

    PubMed  CAS  Article  Google Scholar 

  34. Fliss H., Gattinger D. (1996) Apoptosis in ischemic and reperfused rat myocardium. Circ. Res. 79: 949–956

    PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported by research grant from the Nation Science Council (NSC93–2320-B-016–039 to YM Lee), Taipei, Taiwan, ROC.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Yen-Mei Lee.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Chen, SY., Hsiao, G., Hwang, HR. et al. Tetramethylpyrazine induces heme oxygenase-1 expression and attenuates myocardial ischemia/reperfusion injury in rats. J Biomed Sci 13, 731–740 (2006). https://doi.org/10.1007/s11373-006-9098-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11373-006-9098-2

Keywords

  • arrhythmias
  • HO-1
  • myocardial ischemia
  • neutrophils
  • oxidative stress
  • reperfusion injury
  • tetramethylpyrazine